论文信息 - FCGR2A/CD32A and FCGR3A/CD16A Variants and EULAR Response to Tumor Necrosis Factor-α Blockers in Psoriatic Arthritis: A Longitudinal Study with 6 Months of Followup - 字舞流文

FCGR2A/CD32A and FCGR3A/CD16A Variants and EULAR Response to Tumor Necrosis Factor-α Blockers in Psoriatic Arthritis: A Longitudinal Study with 6 Months of Followup

J. Cañete | R. Sanmartí | M. Alsina | F. Lozano | C. Moll | R. López-Mejías | C. Montilla | J. Fernández-Sueiro | J. Ramírez | Maite Arias